Article

Driving amyloid toxicity in a yeast model by structural changes: a molecular approach.

Institut de Biochimie et Génétique Cellulaires, IBGC CNRS UMR 5095, Université Bordeaux 2 Victor Segalen, 1 rue Camille Saint Saëns, 33077 Bordeaux cedex, France.
The FASEB Journal (impact factor: 5.71). 03/2009; 23(7):2254-63. DOI:10.1096/fj.08-125724 pp.2254-63
Source: PubMed

ABSTRACT The amyloid aggregation pathway is a multistep process, and many in vitro studies have highlighted the role of particular intermediates in the cellular toxicity of various amyloid diseases. In a previous study, we generated a yeast toxic mutant (M8) of the harmless model amyloid protein Het-s(218-289). In this study, we compared the aggregation characteristics of the wild-type (WT) and the toxic mutant at the molecular level. Both proteins formed fibrillar amyloid aggregates but with different dye-binding properties and X-ray diffraction patterns. The toxic amyloid formed very unusual short (80 nm) unbranched fibers visible on transmission electron microscopy. Fourier transform infrared spectroscopy demonstrated that M8 beta-sheets were essentially organized into a mixed parallel and antiparallel structure, whereas the WT protein displayed a predominantly parallel organization. Cellular toxicity may therefore be related to assembly of the toxic amyloid in a new aggregation pathway.

0 0
 · 
0 Bookmarks
 · 
46 Views

Keywords

aggregation characteristics
 
amyloid aggregation pathway
 
antiparallel structure
 
cellular toxicity
 
different dye-binding properties
 
fibrillar amyloid aggregates
 
Fourier
 
harmless model amyloid protein Het-s(218-289)
 
infrared spectroscopy
 
mixed parallel
 
molecular level
 
new aggregation pathway
 
toxic amyloid
 
transmission electron microscopy
 
unusual short
 
various amyloid diseases
 
vitro studies
 
X-ray diffraction patterns
 
yeast toxic mutant